EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer

P Cornford, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, J Bellmunt, M Bolla, E Briers… - European urology, 2017 - Elsevier
Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)-European Society for Radiotherapy & Oncology (ESTRO)-International Society of …

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

A Heidenreich, J Bellmunt, M Bolla, S Joniau, M Mason… - European urology, 2011 - Elsevier
OBJECTIVE: Our aim was to present a summary of the 2010 version of the European
Association of Urology (EAU) guidelines on the screening, diagnosis, and treatment of …

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer

A Heidenreich, PJ Bastian, J Bellmunt, M Bolla… - European urology, 2014 - Elsevier
Objective To present a summary of the 2013 version of the European Association of Urology
(EAU) guidelines on the treatment of advanced, relapsing, and castration-resistant prostate …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer

P Cornford, J Bellmunt, M Bolla, E Briers, M De Santis… - European urology, 2017 - Elsevier
Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)–European Society for Radiotherapy & Oncology (ESTRO)–International Society of …

EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from …

TBL Lam, S MacLennan, PPM Willemse, MD Mason… - European urology, 2019 - Elsevier
Background There is uncertainty in deferred active treatment (DAT) programmes, regarding
patient selection, follow-up and monitoring, reclassification, and which outcome measures …

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013

A Heidenreich, PJ Bastian, J Bellmunt, M Bolla… - European urology, 2014 - Elsevier
Context The most recent summary of the European Association of Urology (EAU) guidelines
on prostate cancer (PCa) was published in 2011. Objective To present a summary of the …

EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease

A Heidenreich, J Bellmunt, M Bolla, S Joniau… - Actas Urológicas …, 2011 - Elsevier
Objective Our aim was to present a summary of the 2010 version of the European
Association of Urology (EAU) guidelines on the screening, diagnosis, and treatment of …

Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management

JA Eastham, GB Auffenberg, DA Barocas… - Journal of …, 2022 - journals.lww.com
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …